What is the main business of Spółdzielnia Farmaceutyczna Spółdzielnia Pracy "Filofarm?

The main business activity of the cooperative focuses on manufacture of pharmaceutical preparations.

When was the cooperative founded?

The cooperative was registered in the Polish National Court Register (KRS) on October 11, 2002.

Where is the headquarters located?

The headquarters is located at: ul. Kazimierza Pułaskiego 39, 85-619 Bydgoszcz.

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the cooperative generated total revenue of $9,910,184, representing an increase of 0.4% compared to 2024.

Yes, in 2025 the cooperative was profitable, achieving a net profit of $900,360, meaning the cooperative decreased its profit by 26.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under materials and energy. This category amounted to $4,857,168 in 2025, representing 55% of all operating expenses.

Farmaceutyczna Spółdzielnia Pracy FilofarmCooperative

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-10-11

Registered address

ul. Kazimierza Pułaskiego 39, 85-619 Bydgoszcz, Poland

Electronic delivery address

AE:PL-68196-55937-HAIGD-25

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 45 days early. All were audited by a statutory auditor.

202502/06/2026
202418/06/2025
202317/06/2024
202216/06/2023
202121/06/2022
202021/06/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 9.91mMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD 900.36kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 8.78mMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 9.64mMedianUSD 883.09kAverageUSD 31.39m

Industry

Trademarks

Farmaceutyczna Spółdzielnia Pracy Filofarm holds 14 active trademarks registered with the Polish Patent Office. 15 marks have expired or were not registered. The first mark was filed in 1997.

Mark	Number	Classes	Status	Protected until
FILOFARM	Z.496217	5	Protected	Feb 21, 2029
FILOFARM Aspargin 17 mg jonów magnezu + 54 mg jonów potasu tabletki Magnesii hydroaspartas + Kalii hydroaspartas	Z.495407	5	Protected	Jan 30, 2029
Filofarm(word)	Z.432881	5	Protected	Sep 1, 2034
FILOFARM	Z.423171	5	Protected	Dec 23, 2033
ASPARGINA(word)	Z.358852	5	Protected	Jul 30, 2029

Mark	Protected until
FILOFARM	Feb 21, 2029
FILOFARM Aspargin 17 mg jonów magnezu + 54 mg jonów potasu tabletki Magnesii hydroaspartas + Kalii hydroaspartas	Jan 30, 2029
Filofarm(word)	Sep 1, 2034
FILOFARM	Dec 23, 2033
ASPARGINA(word)	Jul 30, 2029

Authorized Representatives

Agnieszka Trajder – President

Marek Krzysztof Siuda – Zastępca Prezesa

Manner of representation

Two members of the management board, or one member of the management board together with an attorney-in-fact.

Supervisory board

Małgorzata Andrearczyk – Supervisory Board Member

Wioleta Katarzyna Bartoszak – Supervisory Board Member

Damian Piotr Łaski – Supervisory Board Member

Jacek Retkowski – Supervisory Board Member

Krzysztof Zwoliński – Supervisory Board Member

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

PKO Bank Polski
92 1020 4900 0000 8302 3133 5897
PKO Bank Polski
79 1020 1068 0000 1002 0328 4429
Bank Pekao SA
11 1240 1183 1111 0011 0469 9213

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$53,411$53,411
Buildings and premises	$2.1M$2,066,141

Public aid

5 public aid cases recorded, with a total value of $498,951.

Grant date	Purpose	Gross amount	Granting body
Sep 7, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$77,890$77,890	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Aug 20, 2020	Other crisis aid	$120.7K$120,698	PREZYDENT MIASTA BYDGOSZCZ
May 18, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$286.7K$286,720	Polski Fundusz Rozwoju S.A.

European Funds

Start	Project	EU co-financing	Programme
2020-07-01	Working capital grant for Farmaceutyczna Spółdzielnia Pracy FILOFARM	$77,890$77,890	Operational Programme Smart Growth

Regulatory authorisations

Authority	Type	Status
BDO	Waste generation	Active

Competitors

	Name	Revenue	Website
	Farmaceutyczna Spółdzielnia Pracy GalenaCooperative	$14,804,854.15	galena.pl

Change history

Date	Event
2020-12-15	Address change (K. Pułaskiego 39, 85-619, Bydgoszcz → Ul. Kazimierza Pułaskiego 39, 85-619, Bydgoszcz)
2017-09-18	PKD change (Removed: 11 codes)
2008-07-28	Switch to PKD 2007 (1 PKD 1997 code → 20 PKD 2007 codes)
2007-12-28	Name change (Farmaceutyczna Spółdzielnia Pracy "filofarm" W Bydgoszczy → Farmaceutyczna Spółdzielnia Pracy "filofarm")
2002-10-11	Entered in the register

FAQ

Last updated: 2026-06-02